Friday, August 6, 2021

Over 200 tests for every batch: Bharat Biotech on Covaxin quality concern

Each batch of the vaccine was subjected to more than 200 quality control tests at its facilities, followed by submission samples to CDL. Only based on approval by CDL are batches released commercially

from Today's Paper https://ift.tt/3rWAHRV
via

No comments:

Post a Comment

If you have any doubts please let me know!

India's low score on GVC a starting point for recovery from pandemic: AIIB

India rated 7.4 percentage points below the average global value chain participation rate for emerging economies from Today's Paper ht...